IP Library Granted Patent US 7,932,239
Granted Patent B2
US 7,932,239 · App. 11/412,353 · Granted Apr 26, 2011

Methods of and compositions for reducing neuronal cell death

Assignee: Wisconsin Alumni Research Foundation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,932,239
App. No.
11/412,353
Granted
Apr 26, 2011
Kind
B2
Abstract

Methods and compositions involving a class of boron-protected phenylphosphine agents having increased cell permeability and having improved chemical stability for treating or for preventing neuronal cell death-related diseases or conditions in a human or a non-human animal.

Claims (15)

1. A method for protecting a neuronal cell from cell death, the method comprising the step of:

exposing one or more neuronal cells to an effective amount of a pharmaceutical composition comprising a compound having a formula of:

wherein two of R 1 to R 3 are aryl groups or substituted aryl groups and one of R 1 -R 3 is CH 2 CH 2 COOCH 3 ; and

a pharmaceutically acceptable carrier.

2. The method of claim 1 , wherein the aryl group is a phenyl group and the substituted aryl group is a substituted phenyl group.

3. The method of claim 1 , wherein the substituted aryl group comprises an aromatic ring directly linked to the phosphorus.

4. The method of claim 1 , wherein the compound defined by the formula is (3-propionic acid methyl ester)diphenylphosphine borane complex.

5. The method of claim 1 , wherein the neuronal cells are neurons.

6. The method of claim 5 , wherein the neurons are retinal ganglion cells.

7. The method of claim 1 , wherein the neuronal cells are human or non-human animal neuronal cells.

8. The method of claim 1 , wherein the neuronal cells are protected in vivo in a human or in a non-human animal.

9. A pharmaceutical composition comprising:

a compound having a formula of:

wherein two of R 1 -R 3 are aryl groups or substituted aryl groups and one of R 1 -R 3 is CH 2 CH 2 COOCH 3 ; and

a pharmaceutically acceptable carrier.

Assignments (3)
CONFIRMATORY LICENSE Recorded Jul 12, 2011
From: WISCONSIN ALUMNI RESEARCH FOUNDATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 026572/0589 →
CONFIRMATORY LICENSE Recorded Dec 18, 2008
From: UNIVERSITY OF WISCONSIN-MADISON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021999/0117 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 13, 2006
From: RAINES, RONALD T.; LEVIN, LEONARD A.
To: WISCONSIN ALUMNI RESEARCH FOUNDATION
Reel/Frame 017925/0379 →
Continuity (2)
Provisional Application 60675835 · Apr 28, 2005
Related Publication 20060258622A1 · Nov 16, 2006